B1047 - Epigenetic changes in the development of obesity and associated metabolic disorders - 27/09/2010
Obesity and its related metabolic disorders represent a major social, economic and health burden.
There is immense interest in epigenetic processes and the role that they might play in mediating
complex disease risk through their influence on gene regulation. This project adopts an
epidemiological approach, including the development of novel data analysis methods, and aims to
further our understanding of the contribution made by epigenetic mechanisms to obesity and its
sequelae, including non alcoholic fatty liver disease.
This study will measure DNA methylation patterns in children at birth and at age 15 and relate
these to a wide array of exposures and obesity-related traits, and importantly, the trajectory of
these traits. It represents by far the largest study of DNA methylation and its association with
obesity-related exposures (beginning in utero) and outcomes to date. The study will utilise a world
leading longitudinal study which has followed children from birth to age 17 (with future follow-up
planned) and has amassed an unprecedented amount of data on these individuals. To
complement large, well-powered human epidemiological studies of peripheral blood DNA
methylation, analysis of tissue specific DNA methylation will be analysed in human biopsy samples
and both DNA methylation and gene expression will be analysed in a range of target tissues in
animal models.
The study will identify obesity-related DNA methylation patterns using the Illumina 450k human
methylation array in 250 children at birth and age 15. From these data a custom panel of
methylation sites associated with obesity-related exposures and the phenotype itself will be
designed. A total of 1,200 children will then be analysed to establish the relationship between
methylation variation and obesity and its associated metabolic disorders. In addition the
association of DNA methylation signatures with common genetic variation will be investigated and
data analysis techniques developed to strengthen causal inference. Finally tissue specific
methylation patterns will be explored using human liver tissue and multiple tissues from animal
models of obesity.
The study will make a significant contribution to the emerging field of epigenetic epidemiology and
the data arising will be made available to the wider scientific community.